4.8 Article

Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses

Journal

IMMUNITY
Volume 55, Issue 12, Pages 2405-+

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2022.10.015

Keywords

-

Categories

Funding

  1. Intramural Research Program of the Vaccine Research Center, NIAID, NIH
  2. Intramural Research Program of Di-vision of Intramural Research, NIAID, NIH
  3. Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]
  4. Leidos Biomedical Research, Inc.
  5. Bill and Melinda Gates Foundation

Ask authors/readers for more resources

Immunization with HA stem immunogens derived from different influenza A viruses can elicit cross-group protective immunity and neutralizing antibody responses in mice, ferrets, and nonhuman primates.
Current influenza vaccines predominantly induce immunity to the hypervariable hemagglutinin (HA) head, requiring frequent vaccine reformulation. Conversely, the immunosubdominant yet conserved HA stem har-bors a supersite that is targeted by broadly neutralizing antibodies (bnAbs), representing a prime target for universal vaccines. Here, we showed that the co-immunization of two HA stem immunogens derived from group 1 and 2 influenza A viruses elicits cross-group protective immunity and neutralizing antibody re-sponses in mice, ferrets, and nonhuman primates (NHPs). Immunized mice were protected from multiple group 1 and 2 viruses, and all animal models showed broad serum-neutralizing activity. A bnAb isolated from an immunized NHP broadly neutralized and protected against diverse viruses, including H5N1 and H7N9. Genetic and structural analyses revealed strong homology between macaque and human bnAbs, illus-trating common biophysical constraints for acquiring cross-group specificity. Vaccine elicitation of stem -directed cross-group-protective immunity represents a step toward the development of broadly protective influenza vaccines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available